Myeloablative Autologous Transplantation of CD34 + Selected Hematopoietic Stem Cells (HSCT) vs Monthly Intravenous Cyclophosphamide (CY) for Severe Scleroderma with Internal Organ Involvement: Outcomes of a Randomized North American Clinical Trial

التفاصيل البيبلوغرافية
العنوان: Myeloablative Autologous Transplantation of CD34 + Selected Hematopoietic Stem Cells (HSCT) vs Monthly Intravenous Cyclophosphamide (CY) for Severe Scleroderma with Internal Organ Involvement: Outcomes of a Randomized North American Clinical Trial
المؤلفون: Lynettee Keyes-Elstein, Linda M. Griffith, Daniel E. Furst, Maureen D. Mayes, Richard A. Nash, Beverly Welch, Leslie J. Crofford, Keith M. Sullivan, Ellen Goldmuntz, Ashley Pinckney, Sharon Castina, Peter A. McSweeney
المصدر: Biology of Blood and Marrow Transplantation. 23:S23-S24
بيانات النشر: Elsevier BV, 2017.
سنة النشر: 2017
مصطلحات موضوعية: Transplantation, medicine.medical_specialty, business.industry, CD34, Hematology, medicine.disease, Scleroderma, Surgery, Clinical trial, 03 medical and health sciences, Haematopoiesis, 0302 clinical medicine, Intravenous cyclophosphamide, 030220 oncology & carcinogenesis, Autologous transplantation, Medicine, Organ involvement, Stem cell, business, 030215 immunology
تدمد: 1083-8791
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6221d46e0a149f866d4ae4f7967d5f80Test
https://doi.org/10.1016/j.bbmt.2017.01.012Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........6221d46e0a149f866d4ae4f7967d5f80
قاعدة البيانات: OpenAIRE